
Renalytix AI plc RNLX
Quartalsbericht 2024-Q3
hinzugefügt 19.11.2024
Renalytix AI plc Kurshistorie 2011-2026 | RNLX
Kurshistorie Jährlich Renalytix AI plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.21 | 1.51 | 1.51 | 15.9 | 16 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16 | 0.21 | 7.03 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 19.11 | 0.47 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 5.31 | 4.89 % | $ 156 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 20.49 | -2.36 % | $ 215 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 38.74 | -0.41 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
208 | $ 228.43 | -0.21 % | $ 167 B | ||
|
DexCom
DXCM
|
126 | $ 66.86 | 0.74 % | $ 25.8 B | ||
|
BioNano Genomics
BNGO
|
2.79 | $ 1.56 | 1.96 % | $ 1.98 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
1.53 | $ 11.42 | 0.35 % | $ 324 M | ||
|
IQVIA Holdings
IQV
|
197 | $ 225.43 | 0.01 % | $ 40.9 B | ||
|
Exact Sciences Corporation
EXAS
|
50.3 | $ 101.79 | 0.23 % | $ 18.9 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 25.95 | -1.24 % | $ 785 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
CareDx, Inc
CDNA
|
9.69 | $ 19.2 | 1.91 % | $ 1.03 B | ||
|
Celcuity
CELC
|
10.1 | $ 100.08 | 0.34 % | $ 3.95 B | ||
|
Anixa Biosciences
ANIX
|
2.22 | $ 3.09 | -0.96 % | $ 98.6 K | ||
|
Myriad Genetics
MYGN
|
10.7 | $ 6.22 | 1.14 % | $ 564 M | ||
|
ENDRA Life Sciences
NDRA
|
4.1 | $ 4.26 | -5.96 % | $ 2.29 M | ||
|
NeoGenomics
NEO
|
12.1 | $ 11.76 | - | $ 1.49 B | ||
|
Guardant Health
GH
|
47.6 | $ 101.08 | -1.04 % | $ 12.4 B | ||
|
National Research Corporation
NRC
|
41.1 | $ 18.42 | -1.89 % | $ 452 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
OPKO Health
OPK
|
1.75 | $ 1.26 | 0.4 % | $ 874 M | ||
|
Precipio
PRPO
|
6.7 | $ 24.92 | 8.46 % | $ 32.3 M | ||
|
Personalis
PSNL
|
4.28 | $ 7.76 | -2.52 % | $ 460 M | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Illumina
ILMN
|
103 | $ 132.27 | 0.85 % | $ 21 B | ||
|
Charles River Laboratories International
CRL
|
166 | $ 200.24 | 0.38 % | $ 10.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
172 | $ 172.79 | -0.43 % | $ 19.2 B | ||
|
Biodesix
BDSX
|
0.71 | $ 6.84 | 0.51 % | $ 887 M | ||
|
Koninklijke Philips N.V.
PHG
|
25.5 | $ 27.14 | 0.22 % | $ 20 B | ||
|
Laboratory Corporation of America Holdings
LH
|
252 | $ 250.12 | -0.3 % | $ 21 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 186.86 | 2.55 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
457 | $ 666.09 | -1.54 % | $ 54.9 B | ||
|
Lantheus Holdings
LNTH
|
93.4 | $ 66.89 | 0.51 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
1.41 K | $ 1 395.51 | 0.09 % | $ 29.6 B | ||
|
Agilent Technologies
A
|
139 | $ 136.02 | -0.04 % | $ 41.4 B |